CDK2检测试剂盒

CDK2检测试剂盒，CDK2 Assay Kit，旨在以 KinaseGlo MAX 作为检测试剂，用于测定细胞周期蛋白依赖性激酶2/细胞周期蛋白A2的活性，用于筛选和活性分析相关应用。更多视频请关注视频号【艾维缔】。哔哩哔哩【IVDSHOW】。抖音【军哥聊表观】。

关键词

CDK2检测试剂盒

所属分类

表观酶活检测

目录号

79599

获取报价

产品组分

内容	型号	规格	储存温度
CDK2检测试剂盒	79599-01	96次	-20°C
CDK2检测试剂盒	79599-02	384次	-20°C
操作手册	1	1	常温

文件资源

营销中心
注意事项

保存建议厂家推荐蓝冰运输。当您收到产品后，按照说明书建议保存于-20°C。
FAQ
References

Uzma A. et. al., Nature Review Drug Discovery 14:130-146 (2015)

Thiazole-Derived Dual EGFR/CDK-2 Inhibitors: Rational Design, Synthesis, In Vitro Anticancer Evaluation, Mechanistic Profiling, and Computational Binding Analysis.

Date: 2026 Jul   Journal: Archiv der Pharmazie   Authors: Nasr R, Nafie MS, Haffez H, Moustafa MAA, El-Kerdawy MM, Ali AR

Antimicrobial, anticancer activities and molecular docking of eco-friendly chitosan nanocapsule loaded with biosynthesized titanium nanoparticles by Aspergillus flavus.

Date: 2026   Journal: Frontiers in microbiology   Authors: El-Gazzar N, Rafat M, Rabie G, Sitohy B

In Silico and in vitro evaluation of the anticancer effect of a 1,5-Benzodiazepin-2-One derivative (3b) revealing potent dual inhibition of HER2 and HDAC1.

Date: 2025 Apr 18   Journal: Scientific reports   Authors: Al-Theyab NS, Bakheit AH, Lahmidi S, Alanazi MM, Ali AM, Azzaoui K, Essassi EM, Mague JT, Hefnawy M, Alanazi MM, Alanazi AS

Design, Synthesis and Molecular Modeling of Pyrazolo[1,5-a]pyrimidine Derivatives as Dual Inhibitors of CDK2 and TRKA Kinases with Antiproliferative Activity.

Date: 2024 Dec 10   Journal: Pharmaceuticals (Basel, Switzerland)   Authors: Attia MH, Lasheen DS, Samir N, Taher AT, Abdel-Aziz HA, Abou El Ella DA

Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs).

Date: 2024 Jun 11   Journal: Cell death discovery   Authors: Schmitt L, Hoppe J, Cea-Medina P, Bruch PM, Krings KS, Lechtenberg I, Drießen D, Peter C, Bhatia S, Dietrich S, Stork B, Fritz G, Gohlke H, Müller TJJ, Wesselborg S

The role of RNF138 in DNA end resection is regulated by ubiquitylation and CDK phosphorylation.

Date: 2024 Mar   Journal: The Journal of biological chemistry   Authors: Locke AJ, Abou Farraj R, Tran C, Zeinali E, Mashayekhi F, Ali JYH, Glover JNM, Ismail IH

Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties.

Date: 2024 Feb 16   Journal: BMC chemistry   Authors: Sayed EM, Bakhite EA, Hassanien R, Farhan N, Aly HF, Morsy SG, Hassan NA

Novel benzo chromene derivatives: design, synthesis, molecular docking, cell cycle arrest, and apoptosis induction in human acute myeloid leukemia HL-60 cells.

Date: 2023 Dec   Journal: Journal of enzyme inhibition and medicinal chemistry   Authors: Abd El-Hameed RH, Mohamed MS, Awad SM, Hassan BB, Khodair MAE, Mansour YE

Synthesis and Evaluation of Some New 4H-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations.

Date: 2022 Jul 19   Journal: Pharmaceuticals (Basel, Switzerland)   Authors: El-Sayed NNE, Zaki MEA, Al-Hussain SA, Ben Bacha A, Berredjem M, Masand VH, Almarhoon ZM, Omar HS

Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells.

Date: 2022 May 20   Journal: Nature communications   Authors: Zhang J, Gan Y, Li H, Yin J, He X, Lin L, Xu S, Fang Z, Kim BW, Gao L, Ding L, Zhang E, Ma X, Li J, Li L, Xu Y, Horne D, Xu R, Yu H, Gu Y, Huang W